Page 73 - 86_01

ANALES
RANF
www.analesranf.com
Mechanisms of Resistance Vessel Endothelial Dysfunction Induced by Car-
diometabolic Risk Factors. J Am Heart Assoc. 2018; 7(4). pii: e007675.
46. McCurley A, Pires PW, Bender SB, Aronovitz M, Zhao MJ, Metzger D,
Chambon P, Hill MA, Dorrance AM, Mendelsohn ME, Jaffe IZ. Direct regu-
lation of blood pressure by smooth muscle cell mineralocorticoid receptors.
Nat Med. 2012; 18(9):1429-33.
47. Gueret A, Harouki N, Favre J, Galmiche G, Nicol L, Henry JP, Besnier M,
Thuillez C, Richard V, Kolkhof P, Mulder P, Jaisser F, Ouvrard-Pascaud A.
Vascular Smooth Muscle Mineralocorticoid Receptor Contributes to Coronary
and Left Ventricular Dysfunction After Myocardial Infarction. Hypertension.
2016; 67(4):717-23.
48. Min LJ, Mogi M, Iwanami J, Li JM, Sakata A, Fujita T, Tsukuda K, Iwai M,
Horiuchi M. Cross-talk between aldosterone and angiotensin II in vascular
smooth muscle cell senescence. Cardiovasc Res. 2007; 76(3):506-16.
49. Sherajee SJ, Fujita Y, Rafiq K, Nakano D, Mori H, Masaki T, Hara T, Kohno
M, Nishiyama A, Hitomi H. Aldosterone induces vascular insulin resistance
by increasing insulin-like growth factor-1 receptor and hybrid receptor. Ar-
terioscler Thromb Vasc Biol. 2012; 32(2):257-63.
50. Sun Y, Zhang J, Lu L, Chen SS, Quinn MT, Weber KT. Aldosterone-induced
inflammation in the rat heart : role of oxidative stress. Am J Pathol. 2002
161(5):1773-81.
51. Nakano S, Kobayashi N, Yoshida K, Ohno T, Matsuoka H. Cardioprotective
mechanisms of spironolactone associated with the angiotensin-converting
enzyme/epidermal growth factor receptor/extracellular signal-regulated
kinases, NAD(P)H oxidase/lectin-like oxidized low-density lipoprotein re-
ceptor-1, and Rho-kinase pathways in aldosterone/salt-induced hyper-
tensive rats. Hypertens Res. 2005; 28(11):925-36.
52. Newfell BG, Iyer LK, Mohammad NN, McGraw AP, Ehsan A, Rosano G,
Huang PL, Mendelsohn ME, Jaffe IZ. Aldosterone regulates vascular gene
transcription via oxidative stress-dependent and -independent pathways.
Arterioscler Thromb Vasc Biol. 2011; 31(8):1871-80.
53. Harvey AP, Montezano AC, Hood KY, Lopes RA, Rios F, Ceravolo G, Graham
D, Touyz RM. Vascular dysfunction and fibrosis in stroke-prone spontane-
ously hypertensive rats: The aldosterone-mineralocorticoid receptor-Nox1
axis. Life Sci. 2017; 179:110-119.
54. Hirono Y, Yoshimoto T, Suzuki N, Sugiyama T, Sakurada M, Takai S, Ko-
bayashi N, Shichiri M, Hirata Y. Angiotensin II receptor type 1-mediated
vascular oxidative stress and proinflammatory gene expression in aldos-
terone-induced hypertension: the possible role of local renin-angiotensin
system. Endocrinology. 2007; 148(4):1688-96.
55. Vanhoutte PM, Zhao Y, Xu A, Leung SW. Thirty Years of Saying NO: Sour-
ces, Fate, Actions, and Misfortunes of the Endothelium-Derived Vasodilator
Mediator. Circ Res. 2016; 119(2):375-96.
56. Förstermann U, Xia N, Li H. Roles of Vascular Oxidative Stress and Nitric
Oxide in the Pathogenesis of Atherosclerosis. Circ Res. 2017; 120(4):713-
735.
57. Leopold JA, Dam A, Maron BA, Scribner AW, Liao R, Handy DE, Stanton
Receptor mineralocorticoide extrarrenal. Una posi-
ble nueva diana para combatir el daño vascular.
Ana M. Briones y Raquel Rodrigues-Díez
An Real Acad Farm Vol. 86. Nº 1 (2020) · pp. 61 -73
RC, Pitt B, Loscalzo J. Aldosterone impairs vascular reactivity by decreasing
glucose-6-phosphate dehydrogenase activity. Nat Med. 2007; 13(2):189-
97.
58. Barrera-Chimal J, Prince S, Fadel F, El Moghrabi S, Warnock DG, Kolkhof
P, Jaisser F. Sulfenic Acid Modification of Endothelin B Receptor is Res-
ponsible for the Benefit of a Nonsteroidal Mineralocorticoid Receptor An-
tagonist in Renal Ischemia. J Am Soc Nephrol. 2016; 27(2):398-404.
59. Favre J, Gao J, Zhang AD, Remy-Jouet I, Ouvrard-Pascaud A, Dautreaux
B, Escoubet B, Thuillez C, Jaisser F, Richard V. Coronary endothelial
dysfunction after cardiomyocyte-specific mineralocorticoid receptor ove-
rexpression. Am J Physiol Heart Circ Physiol. 2011; 300(6):H2035-43.
60. Shibata S, Nagase M, Yoshida S, Kawarazaki W, Kurihara H, Tanaka H,
Miyoshi J, Takai Y, Fujita T. Modification of mineralocorticoid receptor func-
tion by Rac1 GTPase: implication in proteinuric kidney disease. Nat Med.
2008; 14(12):1370-6.
61. Nagase M, Ayuzawa N, Kawarazaki W, Ishizawa K, Ueda K, Yoshida S,
Fujita T. Oxidative stress causes mineralocorticoid receptor activation in rat
cardiomyocytes: role of small GTPase Rac1. Hypertension. 2012;
59(2):500-6.
62. Ayuzawa N, Nagase M, Ueda K, Nishimoto M, Kawarazaki W, Marumo T,
Aiba A, Sakurai T, Shindo T, Fujita T. Rac1-Mediated Activation of Mine-
ralocorticoid Receptor in Pressure Overload-Induced Cardiac Injury. Hyper-
tension. 2016; 67(1):99-106.
63. McGraw AP, Bagley J, Chen WS, Galayda C, Nickerson H, Armani A, Caprio
M, Carmeliet P, Jaffe IZ. Aldosterone increases early atherosclerosis and
promotes plaque inflammation through a placental growth factor-depen-
dent mechanism. J Am Heart Assoc. 2013; 2(1):e000018.
64. Marzolla V, Armani A, Mammi C, Moss ME, Pagliarini V, Pontecorvo L,
Antelmi A, Fabbri A, Rosano G, Jaffe IZ, Caprio M. Essential role of ICAM-
1 in aldosterone-induced atherosclerosis. Int J Cardiol. 2017; 232:233-
242.
65. Belden Z, Deiuliis JA, Dobre M, Rajagopalan S. The Role of the Minera-
locorticoid Receptor in Inflammation: Focus on Kidney and Vasculature.
Am J Nephrol. 2017; 46(4):298-314.
66. Ahokas RA, Warrington KJ, Gerling IC, Sun Y, Wodi LA, Herring PA, Lu L,
Bhattacharya SK, Postlethwaite AE, Weber KT. Aldosteronism and peripheral
blood mononuclear cell activation: a neuroendocrine-immune interface.
Circ Res. 2003; 93(10):e124-35.
67. Guzik TJ, Hoch NE, Brown KA, McCann LA, Rahman A, Dikalov S, Goronzy
J, Weyand C, Harrison DG. Role of the T cell in the genesis of angiotensin
II induced hypertension and vascular dysfunction. J Exp Med. 2007;
204(10):2449-60.
68. Sun XN, Li C, Liu Y, Du LJ, Zeng MR, Zheng XJ, Zhang WC, Liu Y, Zhu M,
Kong D, Zhou L, Lu L, Shen ZX, Yi Y, Du L, Qin M, Liu X, Hua Z, Sun S, Yin
H, Zhou B, Yu Y, Zhang Z, Duan SZ. T-Cell Mineralocorticoid Receptor Con-
trols Blood Pressure by Regulating Interferon-Gamma. Circ Res. 2017;
120(10):1584-1597.
71